Ascletis Pharma Financials
| ASCLF Stock | USD 0.24 0.00 0.00% |
Ascletis |
Understanding current and past Ascletis Pharma Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Ascletis Pharma's financial statements are interrelated, with each one affecting the others. For example, an increase in Ascletis Pharma's assets may result in an increase in income on the income statement.
Ascletis Pharma Stock Summary
Ascletis Pharma Inc., a biotechnology company, engages in the research and development, manufacture, marketing, and sale of pharmaceutical products in Mainland China and internationally. In addition, the company is developing ASC40 to treat recurrent glioblastoma, drug resistant breast cancer, and KRAS mutant non-small cell lung cancer ASC61 and ASC63 for advanced solid tumors ASC60 to treat solid tumors and ASC40 for the treatment of acne, Ascletis Pharma Inc. was founded in 2013 and is headquartered in Hangzhou, the Peoples Republic of China. Ascletis Pharma operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 266 people.| Instrument | USA Pink Sheet View All |
| Exchange | PINK Exchange |
| Business Address | Building D, Hangzhou, |
| Sector | Healthcare |
| Industry | Biotechnology |
| Benchmark | Dow Jones Industrial |
| Website | www.ascletis.com |
| Phone | 86 571 8538 9730 |
| Currency | USD - US Dollar |
Ascletis Pharma Key Financial Ratios
There are many critical financial ratios that Ascletis Pharma's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Ascletis Pharma reports annually and quarterly.| Return On Equity | -0.0632 | |||
| Return On Asset | -0.053 | |||
| Number Of Employees | 315 | |||
| Beta | 0.81 |
Ascletis Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Ascletis Pharma's current stock value. Our valuation model uses many indicators to compare Ascletis Pharma value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Ascletis Pharma competition to find correlations between indicators driving Ascletis Pharma's intrinsic value. More Info.Ascletis Pharma is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Ascletis Pharma's earnings, one of the primary drivers of an investment's value.Ascletis Pharma Systematic Risk
Ascletis Pharma's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Ascletis Pharma volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was fourty-five with a total number of output elements of sixteen. The Beta measures systematic risk based on how returns on Ascletis Pharma correlated with the market. If Beta is less than 0 Ascletis Pharma generally moves in the opposite direction as compared to the market. If Ascletis Pharma Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Ascletis Pharma is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Ascletis Pharma is generally in the same direction as the market. If Beta > 1 Ascletis Pharma moves generally in the same direction as, but more than the movement of the benchmark.
Ascletis Pharma January 31, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Ascletis Pharma help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Ascletis Pharma. We use our internally-developed statistical techniques to arrive at the intrinsic value of Ascletis Pharma based on widely used predictive technical indicators. In general, we focus on analyzing Ascletis Pink Sheet price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Ascletis Pharma's daily price indicators and compare them against related drivers.
| Information Ratio | 0.1221 | |||
| Maximum Drawdown | 33.33 |
Complementary Tools for Ascletis Pink Sheet analysis
When running Ascletis Pharma's price analysis, check to measure Ascletis Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ascletis Pharma is operating at the current time. Most of Ascletis Pharma's value examination focuses on studying past and present price action to predict the probability of Ascletis Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ascletis Pharma's price. Additionally, you may evaluate how the addition of Ascletis Pharma to your portfolios can decrease your overall portfolio volatility.
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data |